deltatrials
Unknown NA INTERVENTIONAL 2-arm NCT05951790

Inspiratory Muscle Training (IMT) in Adult People With Pompe Disease (LOPD01)

Efficacy and Feasibility of Inspiratory Muscle Training (IMT) in Adult People With Pompe Disease: a Multicentre, Cross-over Randomized Control Trial (RCT)

Sponsor: Associazione Italiana Glicogenosi (AIG)

Updated 4 times since 2023 Last updated: Jul 11, 2023 Started: Mar 1, 2023 Primary completion: Jun 1, 2023 Completion: Apr 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Glycogen Storage Disease Type II and Pompe Disease (Late-onset) and is currently ongoing. Associazione Italiana Glicogenosi (AIG) leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshotRecruiting~Aug 2025 – present · 9 months · monthly snapshotUnknown

Change History

4 versions recorded
  1. Aug 2025 — Present [monthly]

    Unknown NA

    Status: RecruitingUnknown

  2. Sep 2024 — Aug 2025 [monthly]

    Recruiting NA

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  4. Aug 2023 — Jul 2024 [monthly]

    Recruiting NA

    First recorded

Mar 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Associazione Italiana Glicogenosi (AIG)
  • Associazione Riabilitatori Insufficienza Respiratoria (ArIR)
  • Fondazione Don Carlo Gnocchi Onlus
  • S.C. di Pneumologia Azienda Sanitaria Universitaria Integrata di Trieste
  • U.O.C. AO Ospedali Riuniti Villa Sofia-Cervello, Palermo
Data source: Fondazione Don Carlo Gnocchi Onlus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations